comparemela.com
Home
Live Updates
Kyowa Kirin Will Present New Rocatinlimab Phase 2b Data in Atopic Dermatitis at the American Academy of Dermatology Annual Meeting 2023 : comparemela.com
Kyowa Kirin Will Present New Rocatinlimab Phase 2b Data in Atopic Dermatitis at the American Academy of Dermatology Annual Meeting 2023
/PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announces that data from the Phase 2b study of rocatinlimab (KHK4083/AMG 451), an investigational...
Related Keywords
Louisiana ,
United States ,
Japan ,
New Orleans ,
Tokyo ,
America ,
American ,
Jonathan Silverberg ,
Camilla Chong ,
Ehsanollah Esfandiari ,
Eric Simpson ,
Emma Guttman Yassky ,
Asia Pacific ,
Kyowa Kirin Us Research ,
A Global Specialty Pharmaceutical Company ,
Prnewswire Kyowa Kirin Co Ltd ,
American Academy Of Dermatology ,
Jolla Institute For Immunology ,
Ernestn Morial Convention Center Level ,
Rd Division Of Kyowa Kirin ,
Poster Center ,
American Academy ,
Yoshifumi Torii ,
Executive Officer ,
Vice President ,
Convention Center ,
Angela Williams Phd ,
Numerical Rating Scale ,
Dermatology Life Quality Index ,
Critical Role ,
Orchestrating Inflammation ,
Atopic Dermatitis ,
Product Theater ,
Kyowa Kirin ,
North America ,
comparemela.com © 2020. All Rights Reserved.